Dave Winkler

David_Winkler

Dave has a PhD in radioastronomy and microwave spectroscopy and degrees in chemistry, chemical engineering, and physics. He focuses strongly on fundamental science that can be translated into tangible impact. He has published over 250 research papers (e.g. Chemical Reviews, Nature Materials, Angewandte Chemie, PNAS, Advanced Materials) and book chapters, almost 60 research and client reports, is an inventor on 25 patents. His current H-index is 39 and i10 index (number of papers with >10 citations) is 112. He is the current President of the Federation of Asian Chemical Societies and past President of the Asian Federation for Medicinal Chemistry, both umbrella organisations representing chemical and medicinal chemistry societies in the Asia-Pacific region. He is the recipient a diverse International awards and honours including the Herman Skolnik award from the American Chemical Society (informatics), the Adrien Albert award of the Royal Australian Chemical Institute (medicinal chemistry), the Royal Academy of Engineering (UK) Distinguished Fellowship (bioengineering), the CRC for Polymers Chairman’s Award for Excellence in Commercialisation (drug design), and the CSIRO Medal for Business Excellence. Dave is a Fellow, former Board Chair and current Honorary General Secretary of the Royal Australian Chemical Institute, a Director and member of the Board Executive of Science and Technology Australia, a member of the Australian Academy of Science’s National Committee for Chemistry, member of the Board and Fellow of the Asian Federation for Medicinal Chemistry, He also served on a nomenclature committee of the International Union of Pure and Applied Chemistry, and is the Australian representative on the Pacifichem 2020 organising committee.

An important aspect of his research has involved dissecting the quantitative structure-activity method and rebuilding it with modern mathematical and artificial intelligence methods, and adapting evolutionary methods to design of bioactive molecules and materials for diagnostics, therapeutics, and regeneration. He was a foundation member the CSIRO complex systems science group established and published seminal cited papers in this field.  His most recent work involves modelling the interactions of materials with biology, particular the ability of materials surface chemistry, physicochemical properties and topographies to modulate cell attachment, proliferation and differentiation, and the design of small molecule and peptides to modulate protein-protein interactions as drug leads. His research output is summarised on his Google Scholar and LinkedIn pages.